Viewing Study NCT04726332

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:01 PM
Ignite Modification Date: 2026-01-01 @ 2:51 PM
Study NCT ID: NCT04726332
Status: TERMINATED
Last Update Posted: 2024-05-14
First Post: 2021-01-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)
Sponsor: Exelixis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasm Malignant View
None Epithelial Ovarian Cancer View
None Triple Negative Breast Cancer View
None Hormone Receptor Positive Breast Carcinoma View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cdk7 inhibitor View